• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-1416
Device Problems Premature Discharge of Battery (1057); Inadequate or Insufficient Training (1643)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2022
Event Type  malfunction  
Event Description
It was reported the patient experienced premature battery depletion.A report from the field indicated the patient's implantable pulse generator (ipg) was nearing end of life after thirteen months of use.Analysis of the ipg settings and stimulation usage by engineers revealed an energy use index (eui) index of 10.2 with impedances within normal range; indicating an anticipated approximate 36 months of service.Further review of the battery voltages for the ipg revealed an unexpected drop at the time of implant and a more than usual decline in voltage over the thirteen months of service.No further information has been provided despite good faith efforts.
 
Event Description
It was reported the patient experienced premature battery depletion.A report from the field indicated the patient's implantable pulse generator (ipg) was nearing end of life after thirteen months of use.Analysis of the ipg settings and stimulation usage by engineers revealed an energy use index (eui) index of 10.2 with impedances within normal range; indicating an anticipated approximate 36 months of service.Further review of the battery voltages for the ipg revealed an unexpected drop at the time of implant and a more than usual decline in voltage over the thirteen months of service.No further information has been provided despite good faith efforts.Additional information was received that the patient underwent an explant procedure wherein the ipg was explanted.The patient was doing well postoperatively.
 
Event Description
It was reported the patient experienced premature battery depletion.A report from the field indicated the patient's implantable pulse generator (ipg) was nearing end of life after thirteen months of use.Analysis of the ipg settings and stimulation usage by engineers revealed an energy use index (eui) index of 10.2 with impedances within normal range; indicating an anticipated approximate 36 months of service.Further review of the battery voltages for the ipg revealed an unexpected drop at the time of implant and a more than usual decline in voltage over the thirteen months of service.No further information has been provided despite good faith efforts.Additional information was received that the patient underwent an explant procedure wherein the ipg was explanted.The patient was doing well postoperatively.
 
Manufacturer Narrative
Device analysis performed on the returned ipg revealed the primary cell battery reached the end of service (eos) mode prematurely after 13 months of use.Engineers determined that there was a sudden drop in battery voltage at the time of implant which resulted in early ipg battery depletion and shortened the device longevity.Observations from the field indicated that the ipg had not been exposed to magnetic resonance imaging (mri) or any other high energy exposures during implant or shortly after.The cause of the voltage drop could not be determined as no anomalies were found through laboratory analysis.Based on all the available information, the cause of the reported event could not be established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE GENUS
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key15339807
MDR Text Key299167843
Report Number3006630150-2022-04436
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729985020
UDI-Public08714729985020
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/19/2023
Device Model NumberDB-1416
Device Catalogue NumberDB-1416
Device Lot Number202840
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/04/2022
Initial Date FDA Received09/01/2022
Supplement Dates Manufacturer Received10/11/2022
12/07/2022
Supplement Dates FDA Received11/04/2022
12/15/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/19/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient SexMale
-
-